PLAGL2 and glioblastoma: Next, we then performed a correlation analysis between PLAGL2 and tumor-infiltrating immune cells, including B cells, CD4+T cells, CD8+T cells, macrophages, neutrophils, and DCs by the TIMER database in GBM patients to evaluate the immunotherapy effect.